(Q74764839)
Statements
Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin) (English)
Mismetti P
Laporte-Simitsidis S
Navarro C
Sié P
d'Azemar P
Necciari J
Duret JP
Gaud C
Decousus H